Guided Therapeutics' stock now trading on OTCBB under the symbol GTHP

Download PDF Copy

Reviewed

Guided Therapeutics, Inc.Jun 11 2010

Guided Therapeutics, Inc. (OTCBB: GTHP) today announced that its stock is now trading on the OTCBB under the symbol GTHP, following approval of the listing by the Financial Industry Regulatory Authority (FINRA).

“Listing our stock on the OTCBB is an important milestone for the company as we continue to build value for our shareholders”

"Listing our stock on the OTCBB is an important milestone for the company as we continue to build value for our shareholders," said Mark L. Faupel, Ph.D., chief executive officer and president of Guided Therapeutics. "The listing is one in a series of recent positive events for the company that includes significantly reducing our debt, strengthening our board of directors, simplifying our capital structure and maintaining current filer status with the Securities and Exchange Commission."

Source:

Guided Therapeutics, Inc.

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

Can microbiome discoveries finally become treatments? Scientists show the way

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Scaling B-cell cloning workflows for antibody development

Traditional Chinese medicine targets cholesterol metabolism for cancer treatment

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Once-monthly obesity injection shows double-digit weight loss in major clinical trial

Experts chart path to bring microbiome science into routine clinical care

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.